ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

South Korea · Delayed Price · Currency is KRW

2,655.00

-50.00 (-1.85%)

At close: Oct 2, 2026

Market Cap	16.45B -52.9%
Revenue (ttm)	61.16B +1.5%
Net Income	-2.81B
EPS	-453.69
Shares Out	6.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,825
Open	2,675.00
Previous Close	2,705.00
Day's Range	2,605.00 - 2,725.00
52-Week Range	2,485.00 - 5,920.00
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About KOSDAQ:034940

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers i... [Read more]

Industry Pharmaceutical Preparations

Founded 1964

Employees 269

Stock Exchange KOSDAQ

Ticker Symbol 034940

Full Company Profile

Financial Performance

In 2025, KOSDAQ:034940's revenue was 59.31 billion, a decrease of -5.40% compared to the previous year's 62.69 billion. Losses were -6.81 billion, -29.14% less than in 2024.

Financial Statements